Skip to main content
Monthly or quarterly fremanezumab shows favorable efficacy and tolerability in migraine
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Monthly or quarterly fremanezumab shows favorable efficacy and tolerability in migraine
User login
Username
Password
Reset your password
Concept
Lead
score
Migraine
1
1
Monoclonal Antibody
0
0.93
Biologic Therapy
0
0.58
Body Mass Index
0
0.19
Specialty
Lead
score
Neurology & Neurosurgery
1
1
Family Medicine/Primary Care
0
1
Pharmacist
0
0.58
Edit Tags